Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
about
CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations.Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.Characterization of apoptosis and autophagy through Bcl-2 and Beclin-1 immunoexpression in gestational trophoblastic disease.Expression of human papillomavirus-related proteins and its clinical implication in tonsillar squamous cell carcinoma.MIB-1, Bcl-2 and p53 in odontogenic myxomas of the jaws.
P2860
Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
@en
type
label
Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
@en
prefLabel
Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
@en
P2093
P2860
P356
P1476
Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
@en
P2093
Johannessen AC
Vintermyr OK
P2860
P304
P356
10.1136/JCP.2004.021709
P407
P577
2005-11-01T00:00:00Z